A detailed history of Country Trust Bank transactions in Fulcrum Therapeutics, Inc. stock. As of the latest transaction made, Country Trust Bank holds 30,186 shares of FULC stock, worth $96,897. This represents 0.0% of its overall portfolio holdings.

Number of Shares
30,186
Previous 30,186 -0.0%
Holding current value
$96,897
Previous $187,000 42.78%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 12, 2022

SELL
$4.2 - $24.0 $21,000 - $120,000
-5,000 Reduced 14.21%
30,186 $148,000
Q4 2021

Jan 26, 2022

SELL
$14.0 - $28.44 $30,170 - $61,288
-2,155 Reduced 5.77%
35,186 $622,000
Q4 2020

Feb 03, 2021

BUY
$7.84 - $13.4 $120,398 - $205,783
15,357 Added 69.86%
37,341 $437,000
Q2 2020

Jul 27, 2020

SELL
$9.11 - $22.06 $182,200 - $441,200
-20,000 Reduced 47.64%
21,984 $402,000
Q1 2020

Apr 17, 2020

BUY
$9.49 - $21.26 $398,428 - $892,579
41,984 New
41,984 $501,000

Others Institutions Holding FULC

About Fulcrum Therapeutics, Inc.


  • Ticker FULC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,038,900
  • Market Cap $167M
  • Description
  • Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...
More about FULC
Track This Portfolio

Track Country Trust Bank Portfolio

Follow Country Trust Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Country Trust Bank, based on Form 13F filings with the SEC.

News

Stay updated on Country Trust Bank with notifications on news.